| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | -0.096 | 0.006 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.078 | 0.006 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.088 | 0.006 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.088 | 0.006 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.088 | 0.006 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.094 | 0.007 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.007 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.14 | 0.007 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.081 | 0.008 |